Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

1(25.0%)

Phase 4

1(25.0%)

N/A

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 2(1)

Phase 4(1)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT01237821Not ApplicableCompleted

Comparing OTC Acne Treatment to Prescription Regimen

Role: collaborator

NCT01021787Phase 4Completed

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream

Role: lead

NCT00368563Phase 2Completed

A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin

Role: lead

NCT00326274Phase 3Completed

Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream

Role: lead

All 4 trials loaded